DAIC

JUNE 27, 2024

Planners have designed this year’s program and events to engage physicians, trainees, technologists and healthcare professionals in a complete overview of the cardiovascular CT field. A Welcome Reception will close out the day in the exhibit hall from 6:00 p.m. - for all attendees.

Congenital Heart Disease 105

Congenital Heart Disease Coronary Artery Disease Congenital Heart Disease 105

Circulation

AUGUST 12, 2024

Pathogeneses include connective tissue disorders, smooth muscle contraction disorders, and congenital heart disease, including bicuspid aortic valve, among others. The American Heart Association has published guidelines for diagnosis and management of thoracic aortic disease.

Pediatrics 81

Pediatrics Congenital Heart Disease Aortic valve Bicuspid/Mitral 81

Circulation: Cardiovascular Imaging

JANUARY 13, 2025

Circulation: Cardiovascular Imaging, Ahead of Print. Disorders of the pulmonic valve (PV) receive considerably less attention than other forms of valvular heart disease.

Congenital Heart Disease 40

Congenital Heart Disease Anatomy Congenital Heart Disease 40

Circulation: Cardiovascular Imaging

APRIL 3, 2025

Circulation: Cardiovascular Imaging, Ahead of Print. METHODS:Retrospective study of adults with congenital heart disease who underwent AVR at Mayo Clinic (20032023). METHODS:Retrospective study of adults with congenital heart disease who underwent AVR at Mayo Clinic (20032023).

Aortic valve 40

Aortic valve Aortic Congenital Heart Disease Outcomes 40

DAIC

JUNE 12, 2024

Image courtesy: Philips christine.book Wed, 06/12/2024 - 14:07 June 12, 2024 — Royal Philips has announced its next-generation AI-enabled cardiovascular ultrasound platform to help speed up cardiac ultrasound analysis with proven AI technology and reduce the burden on echocardiography labs.

Ultrasound 105

Ultrasound Cardio Oncology Technology Congenital Heart Disease 105

Circulation: Cardiovascular Imaging

DECEMBER 16, 2024

Circulation: Cardiovascular Imaging, Volume 17, Issue 12 , Page e016882, December 1, 2024. Estimates of RVAC utilizing RVFW-LS were superior to those utilizing TAPSEhowever, only marginally additive to PASP and PVRi at predicting the adverse clinical outcome in patients without a history of repaired congenital heart disease.

Pediatrics 40

Pediatrics Pulmonary Congenital Heart Disease Hypertension 40